natgillin/translations-raw huggingface dataset:
Although weight loss was assessed during 12 months of treatment in both studies, most weight loss occurred within the first 6 months. 
Čeprav so v obeh študijah izgubo telesne mase spremljali tekom 12 mesecev zdravljenja, se je večinoma telesna masa zmanjšala v prvih 6 mesecih.
Think about how much weight you want to lose and then set a target weight. 
Premislite o tem koliko telesne mase želite izgubiti in nato določite svojo ciljno telesno maso.
System organ class and frequency 
Organski sistem in pogostnost
- Write down what you eat in a food diary, including the calorie and fat content. 
- Zapišite kaj pojeste v dnevnik prehranjevanja, vključno z vsebnostmi kalorij in maščob.
Animal studies do not indicate harmful effects with respect to fertility. 
Študije na živalih niso pokazale neugodnega vpliva na plodnost.
Approximately 97% of the administered dose was excreted in faeces and 83% of that as unchanged orlistat. 
Približno 97 % vnesenega odmerka se izloči z blatom, od tega 83 % kot nespremenjen orlistat.
Wait and take the next tablet around your next main meal as usual. 
Počakajte in vzemite naslednji odmerek kot običajno ob vašem naslednjem glavnem obroku.
Talk to your doctor about your risk of developing these conditions. 
Pogovorite se s svojim zdravnikom glede tveganja za razvoj nekaterih zdravstvenih stanj.
The volume of distribution cannot be determined because the active substance is minimally absorbed and has no defined systemic pharmacokinetics. 
Porazdelitvenega volumna ni mogoče določiti, ker se absorbira le neznatna količina učinkovine in ker sistemska farmakokinetika ni opredeljena.
For orlistat, no clinical data on exposed pregnancies are available. 
Za orlistat ni kliničnih podatkov o nosečnicah, ki bi bile izpostavljene zdravilu.
• Chronic malabsorption syndrome 
• kronični malabsorpcijski sindrom
Such diet-related treatment effects may be a signal that you have eaten more fat than you should have done. 
Taki učinki, povezani z vašim prehranjevanjem so lahko znak, da ste zaužili več maščobe, kot bi je smeli.
Make sure your three main meals are well balanced, reduced calorie, and lower-fat. 
Prepričajte se, da so vaši trije glavni obroki dobro uravnoteženi ter vsebujejo znižane kalorije in manj maščob.
To see if your BMI is 28 or above, find your height on the chart. 
Da bi preverili, ali je vaš ITM enak ali večji od 28, v preglednici poiščite svojo višino.
When stored in the carry case: 1 month. 
Pri shranjevanju v škatli za prenašanje: 1 mesec.
Comparison versus placebo: a p<0.001; b p<0.01 
Primerjava glede na placebo: a p < 0,001; b p < 0,01
-4.40 a a p<0.001 versus placebo 
-4,40 a a p < 0,001 glede na placebo
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. 
Obvestite svojega zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa morda boste začeli jemati katero koli drugo zdravilo.
D. CONDITIONS OR RESTRICTIONS WITH REGARD SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT 
D. POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO
Should a significant overdose of orlistat occur, it is recommended that the patient be observed for 24 hours. 
Če bolnik zaužije precej prevelik odmerek orlistata, ga je priporočljivo 24 ur opazovati.
Find your height on the chart. 
V preglednici poiščite svojo višino.
This risk is increased in patients with underlying chronic kidney disease and/or volume depletion. 
To tveganje je večje pri bolnikih s kronično ledvično boleznijo in/ali izgubo tekočine.
If this occurs, the patient should consult a doctor. 
V takem primeru naj se bolnik posvetuje z zdravnikom.
- Incontinence (stools). 
- inkontinenca (blata)
Tell your doctor or pharmacist if any of these side effects gets severe or troublesome. 
Povejte zdravniku ali farmacevtu, če katerikoli od teh neželenih učinkov postane resen ali vam povzroča težave.
- If you take more alli than you should - If you forget to take alli Possible side effects 
- Če ste vzeli večji odmerek zdravila alli, kot bi smeli - Če ste pozabili vzeti zdravilo alli Možni neželeni učinki
Losing weight and maintaining weight loss, for example by improving your diet and increasing your physical activity, can help reduce the risk of serious health problems and help improve your health. 
Znižanje telesne mase in vzdrževanje (naprimer z izboljšanjem prehranjevalnih navad in povečanjem telesne dejavnosti) vam lahko pomaga znižati tveganje za resne zdravstvene težave in pomaga izboljšati vaše zdravje.
If you weigh less than the weight shown for your height, your BMI is below 28 - do not use alli. 
Če tehtate manj, kakor je v preglednici navedeno za vašo višino, je vaš ITM manjši od 28 - ne uporabljajte zdravila alli.
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE alli 60 mg hard capsules: Medicinal product not subject to medical prescription. 
B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE alli 60 mg trde kapsule: Izdaja zdravila je brez recepta v lekarnah.
C. OTHER CONDITIONS AND REQUIRMENTS OF THE MARKETING AUTHORISATION 
C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z ZDRAVILOM
This could be due to a decreased absorption of iodine salts and/or levothyroxine. 
To je lahko povezano z zmanjšano absorpcijo soli joda in/ali levotiroksina.
However, orlistat may indirectly reduce the availability of oral contraceptives and lead to unexpected pregnancies in some individual cases. 
Vendar pa lahko orlistat posredno zmanjša razpoložljivost peroralnih kontraceptivov in v posameznih primerih pripelje do nenačrtovane nosečnosti.
Antidepressants, antipsychotics (including lithium) and benzodiazepines There are some case reports of reduced efficacy of antidepressants, antipsychotics (including lithium) and benzodiazepines coincidental to the initiation of orlistat treatment in previously well controlled patients. 
Antidepresivi, antipsihotiki (vključno z litijem) in benzodiazepini Poročali so o primerih zmanjšane učinkovitosti antidepresivov, antipsihotikov (vključno z litijem) in benzodiazepinov, ki se je pojavila hkrati z začetkom zdravljenja z orlistatom, pri predhodno dobro kontroliranih bolnikih.
The use of orlistat may be associated with kidney stones in patients suffering from chronic kidney disease. 
Uporaba orlistata je lahko povezana z ledvičnimi kamni pri bolnikih, ki imajo kronično bolezen ledvic.
Do not “save up” fat and calorie allowances and then splurge on a high-fat meal or dessert, as you may have done on other weight loss programmes. 
Ne varčujte z maščobo in kalorijami, ki jih boste potem užili v obroku z veliko maščobami ali s sladico, kot ste morda delali pri drugih shujševalnih programih.
Other medicines and alli alli with food and drink 
Zdravilo alli skupaj s hrano in pijačo
Take a multivitamin every day if you are taking alli - alli can lower the levels of some vitamins absorbed by your body. 
Med jemanjem zdravila alli vsak dan zaužijte multivitaminski pripravek - Zdravilo alli lahko zniža raven nekaterih vitaminov, ki jih absorbira vaše telo.
The multivitamin should contain vitamins A, D, E and K. You should take the multivitamin at bedtime, when you will not be taking alli, to help ensure that the vitamins are absorbed. 
Multivitaminski pripravek mora vsebovati vitamine A, D, E in K. Multivitaminski pripravek vzemite pred spanjem, ko ne boste jemali zdravila alli, saj boste tako pomagali zagotoviti, da se vitamini absorbirajo.
Serious side effects It is not known how frequently these side effects occur 
Resni neželeni učinki Ni poznano, kako pogosto se tovrstni neželeni učinki pojavijo.
Each chewable tablet contains 86.79 mg of lactose (as anhydrous) and 6.48 mg of sucrose (as monopalmitate). 
Ena žvečljiva tableta vsebuje 86,79 mg laktoze (brezvodne) in 6,48 mg saharoze (v obliki monopalmitata).
• if you are taking ciclosporin. 
• če jemljete ciklosporin
The gastrointestinal adverse reactions identified from clinical trials with orlistat 60 mg of 18 months to 2 years duration were generally mild and transient. 
Gastrointestinalni neželeni učinki, ki so jih ugotovili v kliničnih preskušanjih s 60 mg orlistata, katera so potekala od 18 mesecev do 2 leti, so bili večinoma blagi in prehodni.
- You should aim to lose weight gradually and steadily. 
- Trudite se da boste izgubljali telesno maso postopoma in stalno.
You may need to stop taking alli. 
Morda boste morali prenehati jemati zdravilo alli.
Chew one tablet three times a day. 
Žvečite eno tableto trikrat dnevno.
BMI is a way to find out if you have a healthy weight, or are overweight, for your height. 
ITM predstavlja pot, kako ugotoviti ali imate zdravo maso ali imate čezmerno telesno maso glede na vašo višino.
Try to start this diet before beginning treatment. 
Z dieto poskusite, preden začnete zdravljenje.
This fat passes out of your body and may cause changes to your bowel movements. 
Maščoba se iz telesa izloči in lahko povzroči nekatere spremembe v vašem črevesju.
• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 
• preobčutljivost na učinkovino ali katerokoli pomožno snov, navedeno v poglavju 6.1
Each tablet contains ingredients that help alli work efficiently in your digestive system and chewing the tablet releases these substances quickly. 
Vsaka tableta vsebuje sestavine, ki pomagajo da zdravilo alli učinkovito deluje v vašem prebavnem sistemu saj žvečenje tablete hitro sprosti učinkovino.
This fat will pass out of the body in your stools (see section 4). 
Maščoba se iz telesa izloči (glejte poglavje 4).
Importance of losing weight 
Pomembnost izgube telesne mase
While taking orlistat, the patient should be on a nutritionally balanced, mildly hypocaloric diet that contains approximately 30% of calories from fat (e.g. in a 2,000 kcal/day diet, this equates to <67 g of fat). 
Med jemanjem orlistata naj bolnik uživa prehransko uravnoteženo, zmerno nizkokalorično dieto, ki vsebuje približno 30 % kalorij iz maščob (v dieti z 2000 kcal/dan to npr. ustreza < 67 g maščob).
EXP In the carry case: 1 month 
V škatli za prenašanje: 1 mesec
The possibility of experiencing gastrointestinal symptoms (see section 4.8) may increase when orlistat is taken with an individual meal or a diet high in fat. 
Možnost pojava gastrointestinalnih simptomov (glejte poglavje 4.8) se lahko poveča, če bolnik orlistat vzame pri enem obroku ali uživa hrano, bogato z maščobami.
Adverse reactions are listed below by system organ class and frequency. 
Neželeni učinki so v nadaljevanju navedeni po organskih sistemih in pogostnosti.
Adverse reactions to orlistat are largely gastrointestinal in nature and related to the pharmacologic effect of the medicinal product on preventing the absorption of ingested fat. 
Neželeni učinki, povezani z jemanjem orlistata, so večinoma gastrointestinalne narave in povezani s farmakološkim učinkom zdravila, ki preprečuje absorpcijo zaužite maščobe.
If you forget to take alli 
Če ste pozabili vzeti zdravilo alli
For information on how to set your calorie and fat targets, see Further helpful information in the blue pages in section 6. 
Za informacije, kako predvideti vnos kalorij in maščob, glejte poglavje Nadaljnje uporabne informacije v modrih straneh poglavja 6.
How long should I take alli for? 
- Kako dolgo naj jemljem zdravilo alli
The chart below will help you find out whether you are overweight and whether alli is right for you. 
Spodnja preglednica vam bo pomagala ugotoviti, ali imate čezmerno telesno maso in ali je zdravilo alli pravo za vas.
You should plan to have three meals per day. 
Načrtujte tako, da boste jedli trikrat dnevno.
Being overweight increases your risk of developing several serious health problems such as diabetes and heart disease. 
Prekomerna telesna masa povečuje tveganje za razvoj nekaterih resnih zdravstvenih težav, kot sta sladkorna bolezen in srčne bolezni.
It is possible that the systemic absorption from 27 mg chewable tablets may be higher than that from 60 mg hard capsules. 
Mogoče je, da je sistemska absorpcija iz 27-mg žvečljive tablete večja kot iz 60 mg trdih kapsul.
The medicinal use of orlistat is unlikely to represent a risk to the aquatic or terrestrial environment. 
Terapevtska uporaba učinkovine orlistat ne predstavlja tveganja za vodno ali kopensko okolje.
- Moderate activity means you burn around 150 calories per day in physical activity, for example, walking three kilometres (2 miles), gardening for 30 to 45 minutes, or running two kilometres (1.25 miles) in 15 minutes. 
Zmerno dejavni ste na primer, če prehodite približno 3 km, 30 do 45 minut vrtnarite ali pretečete 2 kilometra v 15 minutah.
Most of the common side effects related to alli (for example, wind with or without oily spotting, sudden or more frequent bowel motions and soft stools) are caused by the way it works (see section 1). 
Večina neželenih učinkov, povezanih z zdravilom alli (kot naprimer vetrovi (napenjanje) z ali brez oljnih madežev, nenadno ali pogostejše premikanje črevesja in mehko blato), je posledica delovanja zdravila na prebavni sistem (glejte poglavje 1).
- Swallow the capsule whole with water. 
- Kapsulo pogoltnite celo z vodo.
Do not use 
Ne uporabljajte:
- Stick to realistic calorie and fat targets as this is a good way of maintaining your weight loss achievements in the long-term. 
- Določite si realne ciljne vrednosti kalorij in maščob saj je to dobra pot izgube telesne mase in njenega vzdrževanja skozi daljše obdobje
Patients should be advised to adhere to the dietary recommendations they are given (see section 4.2). 
Bolnikom je treba svetovati, da upoštevajo prejeta navodila o dieti (glejte poglavje 4.2).
- Successful weight loss is not just about eating differently for a short period of time before reverting to your old habits. 
- Učinkovita izguba telesne mase ne pomeni zgolj spremembe prehranjevalnih navad za krajše obdobje, ki se nato povrnejo k vašim starim navadam.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. 
Če vam je zdravnik povedal, da ne prenašate nekaterih sladkorjev (imate intoleranco za nekatere sladkorje), se posvetujte s svojim zdravnikom preden vzamete to zdravilo.
If you eat a high-fat meal, do not take more than the recommended dose. 
V kolikor jeste hrano z visoko vsebostjo maščob, ne vzemite večjega odmerka, kot je priporočeno.
That adds up to 3500 fewer calories per week, about the number of calories in 0.5 kg (1 lb) of fat. 
To doprinese do 3.500 kalorij manj na teden, toliko pa je približno število kalorij v 0,5 kg maščob.
Upon discontinuation of therapy, faecal fat content returns to pre-treatment levels, usually within 48 to 72 hours. 
Po prenehanju jemanja se nivo maščob v fecesu povrne na nivo pred jemanjem, navadno v 48 do 72 urah.
Orlistat minimally partitions into erythrocytes. 
Minimalna količina orlistata prehaja v eritrocite.
- The calorie target is the maximum number of calories you will eat each day. 
- Cilj vnosa kalorij je najvišje število kalorij, ki jih boste pojedli dnevno.
Your calorie target alone should allow you to lose weight at a gradual, steady pace of about 0.5 kg (1 lb) per week, without feeling frustrated or deprived. 
Vaša ciljna vrednost kalorij bi vam morala omogočati, da zmanjšate telesno maso s postopnim in stalnim tempom, približno pol kilograma na teden, brez občutka frustracije ali prikrajšanosti.
- Your fat gram target is the maximum number of grams of fat you will eat in each meal. 
- Cilj vnosa v gramih maščob je najvišje število gramov maščobe, kot jih boste pojedli v vsakem obroku.
The effect of orlistat results in an increase in faecal fat as early as 24 to 48 hours after dosing. 
Učinek oristata se odraža v povečanju maščob v fecesu v prvih 24 do 48 urah po jemanju.
See the chart further on in this section. 
Glejte tudi preglednico v nadaljevanju tega poglavja.
Physical activity is an important part of a weight loss programme. 
Telesna dejavnost je pomemben del programa za izgubljanje telesne mase.
ANNEX II A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT 
A. IZDELOVALEC, ODGOVOREN ZA SPROŠČANJE SERIJ B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z
The weight loss induced by orlistat 60 mg conferred other important health benefits after 6 months of treatment in addition to weight loss. 
Izguba telesne mase zaradi jemanja 60 mg orlistata je doprinesla k drugim pomembnim zdravstvenim koristim po 6 mesecih jemanja, poleg izgube telesne mase.
- only take one tablet at a time. 
- Vzemite le eno tableto naenkrat.
Based on human and animal studies, any systemic effects attributable to the lipase-inhibiting properties of orlistat should be rapidly reversible. 
Ugotovitve študij pri človeku in živalih kažejo, da morebitni sistemski zaviralni učinki na lipaze, ki jih lahko pripišemo orlistatu, hitro izzvenijo.
M1 and M3 have an open beta-lactone ring and extremely weak lipase inhibitory activity (1,000and 2,500-fold less than orlistat, respectively). 
M1 in M3 imata odprt betalaktonski obroč in zelo šibak zaviralni učinek na lipazo (1.000- oziroma 2.500-krat šibkejši od orlistata).
- Try to be more physically active before you start taking the capsules. 
- Poskusite postati telesno bolj dejavni preden začnete jemati kapsule.
Decreased prothrombin and increased INR (see sections 4.3 and 4.5) 
Zmanjšana vrednost protrombina in zvišana vrednost INR (glejte poglavji 4.3 in 4.5)
Increase in transaminases and in alkaline phosphatase 
žolčni kamni zvišane vrednosti transaminaz in alkalne fosfataze
What you need to know before you take alli Do not take alli 
Kaj morate vedeti, preden boste vzeli zdravilo alli Ne jemljite zdravila alli
- Oxalate nephropathy (build up of calcium oxalate which may lead to kidney stones). 
- oksalatna nefropatija (nalaganje kalcijevega oksalata, ki lahko vodi do ledvičnih kamnov).
The frequencies of adverse reactions identified during post-marketing use of orlistat are not known as these reactions were reported voluntarily from a population of uncertain size. 
Pogostnosti neželenih učinkov, ki so bile zaznane v študijah po pridobitvi dovoljenja za promet z zdravilom, niso znane, saj so te neželene učinke poročali prostovoljno iz populacije neznane velikosti.
alli 27 mg chewable tablets: Medicinal product not subject to medical prescription. 
alli 27 mg žvečljive tablete: Izdaja zdravila je brez recepta v lekarnah.
See leaflet for further information. 
Za podrobnejše informacije glejte navodilo za uporabo.
- Do not use this medicine after the expiry date which is stated on the carton and bottle after “EXP”. 
- Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in plastenki poleg oznake »Uporabno do«.
Keep a record of what you are eating in a food diary. 
V svoj dnevnik prehranjevanja si zapišite, kaj ste jedli.
In vitro, orlistat is >99% bound to plasma proteins (lipoproteins and albumin were the major binding proteins). 
In vitro se več kot 99 % orlistata veže na beljakovine v plazmi (večinoma na lipoproteine in albumin).
- Try to be more physically active before you start taking the tablets. 
- Poskusite postati telesno bolj dejavni preden začnete jemati tablete.
4.7 Effects on ability to drive and use machines Orlistat has no or negligible influence on the ability to drive and use machines. 
4.7 Vpliv na sposobnost vožnje in upravljanja s stroji Orlistat nima vpliva ali pa ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. 
Za vse morebitne nadaljnje informacije o tem zdravilu se, prosimo, obrnite na predstavništvo imetnika dovoljenja za promet z zdravilom
Pharmacotherapeutic group: antiobesity preparations, excl. diet products, peripherally acting antiobesity products, ATC code A08AB01. 
Farmakoterapevtska skupina: zaviralci apetita, brez dietnih pripravkov, zaviralci apetita s perifernim delovanjem, oznaka ATC: A08AB01
Orlistat may decrease the absorption of antiepileptic medicinal products, leading to convulsions. 
Orlistat lahko zmanjša absorpcijo zdravil za zdravljenje epilepsije, kar lahko vodi do konvulzij.
From clinical studies, it has been estimated that orlistat 60 mg taken three times daily blocks the absorption of approximately 25% of dietary fat. 
Glede na izsledke kliničnih študij je bilo ocenjeno, da 60 mg orlistata trikrat na dan zavira absorpcijo približno 25 % zaužite maščobe.
It exerts its therapeutic activity in the lumen of the stomach and small intestine by forming a covalent bond with the active serine site of the gastric and pancreatic lipases. 
Njegov terapevtski učinek v lumnu želodca in tankem črevesu temelji na nastanku kovalentne vezi z aktivnim serinskim mestom želodčnih in pankreasnih lipaz.
- medicines for depression, psychiatric disorders or anxiousness. 
- zdravila za zdravljenje depresije, duševnih motenj ali tesnobnosti.
alli is not recommended for people taking acarbose. 
Zdravilo alli ni priporočljivo za ljudi, ki jemljejo akarbozo.
People who lose weight and maintain the loss make lifestyle changes, which include changes to what they eat and how active they are. 
Ljudje, ki izgubijo telesno maso in znižano maso vzdržujejo, napravijo tudi spremembe življenjskega sloga, ki vključujejo spremembe v prehranjevanju in telesni aktivnosti.
As it is not known whether orlistat is secreted into human milk, alli is contraindicated during breast-feeding (see section 4.3). 
Ker ni znano, ali orlistat pri ljudeh prehaja v mleko, je zdravilo alli med dojenjem kontraindicirano (glejte poglavje 4.3).
If you have taken too many tablets, contact a doctor as soon as possible. 
Če ste vzeli preveč tablet, se takoj posvetujte z zdravnikom.
Severe allergic reactions - Signs of a severe allergic reaction include: severe breathing difficulties, sweating, rash, itching, swollen face, rapid heart beat, collapse. 
- Znaki hude alergijske reakcije vključujejo: hude težave z dihanjem, potenje, izpuščaj, srbenje, otekel obraz, hiter srčni utrip, kolaps.
For adults with a BMI of 28 or above 
Za odrasle z ITM enakim ali večjim od 28
For further advice see Further helpful information in the blue pages in section 6. 
Za nadaljnje nasvete glejte modre strani v poglavju 6 Nadaljnje uporabne informacije
- Effects on blood clotting in people taking warfarin or other blood-thinning (anti-coagulant) 
- učinkovanje na strjevanje krvi pri osebah, ki jemljejo zdravila za redčenje krvi (antikoagulante),
The safety and efficacy of alli in children below 18 years of age has not been established. 
Pediatrična populacija Varnost in učinkovitost zdravila alli pri otrocih, mlajših od 18 let, nista bili dokazani.
• Pregnancy (see section 4.6) 
• nosečnost (glejte poglavje 4.6)
Children and adolescents This medicine must not be taken by children and adolescents under 18 years old. 
Otroci in mladostniki Zdravilo ni primerno za otroke in mladostnike, mlajše od 18 let.
Orlistat, M1 and M3 are all subject to biliary excretion. 
Orlistat, M 1 in M 3 se izločajo z žolčem.
- Low activity means you do little or no walking, climbing stairs, gardening, or other physical activity on a daily basis. 
- Nizka stopnja telesne dejavnosti pomeni, da hodite malo ali nič, da se redko ali nikoli ne vzpenjate po stopnicah, ne vrtnarite ali ne opravljate druge telesne dejavnosti vsak dan. - Stopnja zmerne telesne dejavnosti pomeni, da potrošite 150 kalorij na dan za telesno dejavnost.
Two double-blind, randomised, placebo-controlled studies in adults with a BMI ≥28 kg/m2 support the efficacy of orlistat 60 mg taken three times daily in conjunction with a hypocaloric, lower-fat diet. 
Dve dvojno slepi, randomizirani, s placebom nadzorovani študiji, izvedeni pri odraslih z ITM ≥ 28 kg/m2 podpirajo učinkovitost zdravila orlistat 60 mg v odmerku trikrat na dan v povezavi z nizkokalorično dieto.
Make every effort to avoid any high-fat meals while taking alli. 
Potrudite se izogniti hrani z visoko vsebnostjo maščob medtem ko jemljete zdravilo alli.
Adults 18 and over 
- Odrasli, stari 18 let in več